These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6098224)

  • 1. Microencapsulation of astiban acid for the treatment of Schistosomiasis mansoni.
    Gopalratnam PC; Mason NS; Sparks RE
    Appl Biochem Biotechnol; 1984; 10():213-20. PubMed ID: 6098224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosoma mansoni: an in vivo study of drug-induced autophagy in the gastrodermis.
    Clarkson J; Erasmus DA
    J Helminthol; 1984 Mar; 58(1):59-68. PubMed ID: 6325532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma mansoni: Astiban-induced damage to tegument and the male reproductive system.
    Otubanjo OA
    Exp Parasitol; 1981 Oct; 52(2):161-70. PubMed ID: 6268434
    [No Abstract]   [Full Text] [Related]  

  • 4. ASTIBAN IN SCHISTOSOMIASIS MANSONI: A CONTROLLED THERAPEUTIC TRIAL IN A NONENDEMIC AREA.
    ZAKI MH; SHOOKHOFF HB; STERMAN M; DERAMOS S
    Am J Trop Med Hyg; 1964 Nov; 13():803-10. PubMed ID: 14222433
    [No Abstract]   [Full Text] [Related]  

  • 5. Schistosoma mansoni: early antimonial treatment of infected mice.
    Ercoli N; Payares G
    Exp Parasitol; 1974 Apr; 35(2):171-8. PubMed ID: 4821447
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of astiban on liver, spleen kidney and bladdet beta.glucuronidase of normal and Schistosoma mansoni infected mice.
    El-Kholy ZA; El-Zoghby SM; Farag HF; El-Toukhy MA; Saad AA; Abdel-Tawab GA
    Biochem Pharmacol; 1979 Nov; 28(21):3171-2. PubMed ID: 230845
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinically available antischistosomal drugs.
    Davis A
    J Toxicol Environ Health; 1975 Nov; 1(2):191-201. PubMed ID: 1206768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further trials with Astiban in schistosomiasis mansoni: the effect of increased dosage.
    Zaki MH; De Ramos S; Shookhoff HB; Sterman M
    Am J Trop Med Hyg; 1966 Sep; 15(5):725-9. PubMed ID: 5917630
    [No Abstract]   [Full Text] [Related]  

  • 9. BIOLOGICAL DISPOSITION OF SOME ANTIMONYL ANTIBILHARZIAL DRUGS: SODIUM ANTIMONY-2,3-MESO-DIMERCAPTO-SUCCINATE (ASTIBAN) IN ANIMALS INFECTED WITH SCHISTOSOMA MANSONI.
    BROWNE HG; SCHULERT AR
    Am J Trop Med Hyg; 1964 Jul; 13():558-71. PubMed ID: 14196053
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatality after antimony dimercapto-succinate ("Astiban").
    SOMERS K; ROSANELLI JD
    Z Tropenmed Parasitol; 1962 Oct; 13():356-61. PubMed ID: 13978159
    [No Abstract]   [Full Text] [Related]  

  • 11. [TREATMENT OF MANSON'S SCHISTOSOMIASIS WITH DIMERCAPTO-SUCCINATE OF ANTIMONY AND SODIUM (ASTIBAN)].
    DA SILVA JR; ARGENTO CA; COUTINHO SG; BRASILHA DO; CORREA GQ; FERREIRA LF
    Hospital (Rio J); 1964 Feb; 65():247-64. PubMed ID: 14136745
    [No Abstract]   [Full Text] [Related]  

  • 12. The suppressive activity of sodium antimony dimercaptosuccinate (TWSB) in experimental infections with Schistosoma mansoni.
    BRUCE JI; SADUN EH
    Am J Trop Med Hyg; 1963 Mar; 12():184-7. PubMed ID: 14016115
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppressive therapy with MsbE and Astiban in hamsters infected with Schistosoma mansoni.
    Baldewsing R
    Trop Geogr Med; 1973 Jun; 25(2):174-8. PubMed ID: 4736841
    [No Abstract]   [Full Text] [Related]  

  • 14. THERAPEUTIC RESULTS OBTAINED WITH INTRAMUSCULAR ASTIBAN IN URINARY SCHISTOSOMIASIS.
    GOTHE KM; VAN DER MEI J; OCHSNER H
    West Afr Med J; 1965 Apr; 14():75-8. PubMed ID: 14286693
    [No Abstract]   [Full Text] [Related]  

  • 15. Astiban therapy of Schistosoma mansoni infection: a quantitative evaluation.
    Farid Z; Bassily S; McConnell E; Davis J
    Ann Trop Med Parasitol; 1967 Sep; 61(3):310-4. PubMed ID: 5625700
    [No Abstract]   [Full Text] [Related]  

  • 16. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREATMENT OF URINARY SCHISTOSOMIASIS IN GHANAIANS WITH TWSB (ASTIBAN).
    WOLFE MS
    Am J Trop Med Hyg; 1964 Nov; 13():811-5. PubMed ID: 14222434
    [No Abstract]   [Full Text] [Related]  

  • 18. CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: INFLUENCE OF DIMERCAPTOSUCCINIC ACID ON THE TOXICITY AND ANTISCHISTOSOMAL ACTIVITY OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND OTHER ANTIMONY COMPOUNDS IN MICE.
    STOHLER HR; FREY JR
    Ann Trop Med Parasitol; 1964 Dec; 58():431-8. PubMed ID: 14249022
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycolytic activities of Schistosoma mansoni and the mode of action of antischistosomal drugs (Ambilhar and Astiban).
    Magzoub M; Maegraith BG
    Ann Trop Med Parasitol; 1969 Sep; 63(3):377-91. PubMed ID: 5373668
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening of three synthetic organic trivalent antimonials for potential antischistosomal activity in mice.
    Ghaleb HA; Shoeb H; el-Kawhary N; el-Borolossy AW; el-Halawany SA; Madkour MK
    J Egypt Med Assoc; 1979; 62(1-2):1-29. PubMed ID: 262466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.